Anzeige
Mehr »
Mittwoch, 29.10.2025 - Börsentäglich über 12.000 News
Atomkraft feiert Comeback: Uran wird wieder zum strategischen Rohstoff - Anleger stehen Schlange
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12ETN | ISIN: CA98420N1050 | Ticker-Symbol: XP0
Tradegate
28.10.25 | 20:10
36,400 Euro
-0,55 % -0,200
1-Jahres-Chart
XENON PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
XENON PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
36,20037,40007:50
36,20037,40007:30

Aktuelle News zur XENON PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.10.Xenon Pharmaceuticals Inc. - 8-K, Current Report1
16.10.Xenon Pharmaceuticals Appoints Tucker Kelly As New CFO-
16.10.Xenon Pharmaceuticals Inc.: Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer248VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical...
► Artikel lesen
07.10.Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)68VANCOUVER, British Columbia and BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical...
► Artikel lesen
07.10.Stifel reiterates Buy rating on Xenon Pharmaceuticals stock, cites pain portfolio2
03.09.Wells Fargo assumes coverage on Xenon Pharmaceuticals stock with Overweight rating5
XENON PHARMACEUTICALS Aktie jetzt für 0€ handeln
03.09.Wells Fargo startet Coverage für Xenon Pharmaceuticals mit "Overweight"-Rating2
29.08.Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)167VANCOUVER, British Columbia and BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical...
► Artikel lesen
11.08.Xenon Pharmaceuticals Inc. - 10-Q, Quarterly Report2
11.08.Xenon Pharma GAAP EPS of $1.07 beats by $2.065
11.08.Xenon Pharmaceuticals Inc.: Xenon Reports Second Quarter 2025 Financial Results & Business Update241- Phase 3 azetukalner X-TOLE2 FOS study patient recruitment complete, with topline data anticipated in early 2026- Phase 3 azetukalner neuropsychiatric studies underway with X-NOVA3 in MDD and X-CEED...
► Artikel lesen
11.08.Xenon Pharmaceuticals Inc. - 8-K, Current Report1
08.08.A Look Ahead: Xenon Pharmaceuticals' Earnings Forecast3
04.08.Xenon Pharmaceuticals Inc.: Xenon to Report Q2 2025 Financial Results on August 11, 202511
01.08.Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)118VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing...
► Artikel lesen
03.07.Xenon Pharmaceuticals Inc. - 8-K, Current Report2
27.06.Xenon Pharmaceuticals in Russell 3000 und Russell 2000 Indizes aufgenommen10
27.06.Xenon Pharmaceuticals added to Russell 3000 and 2000 indexes2
27.06.Xenon Pharmaceuticals Inc.: Xenon Joins the Russell 3000 and Russell 2000 Indexes1
26.06.Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)152VANCOUVER, British Columbia and BOSTON, June 26, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing...
► Artikel lesen
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1